| (1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0;{2,9}.0;{4,8}.0;{13,18}]icosa-14,17-dien-16-one |
| (1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-DIFLUORO-11-HYDROXY-8-(2-HYDROXYACETYL)-6,6,9,13-TETRAMETHYL-5,7-DIOXAPENTACYCLO[10.8.0.0(2),?.0?,?.0(1)(3),(1)?]ICOSA-14,17-DIEN-16-ONE |
| (2S,6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10,10-tetramethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[ |
| (2S,6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10,10-tetramethyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one |
| (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one |
| (4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one |
| 010F525 |
| 0CD5FD6S2M |
| 2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one |
| 4b,12-Difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one |
| 6-alpha,9-alpha-Difluoro-16-alpha-hydroxyprednisolone 16,17-acetonide |
| 6.alpha.-Fluorotriamcinolone acetonide |
| 6.Alpha., 9.alpha.-Difluoro-16.alpha.-h |
| 6.alpha., 9.alpha.-Difluoro-16.alpha.-hydroxyprednisolone 16,17-acetonide |
| 6.alpha.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone |
| 6.alpha.,17-acetonide |
| 6.Alpha.,9-Difluoro |
| 6.alpha.,9-Difluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone |
| 6.alpha.,9.alpha.-Difluoro-16.alpha.-hydroxyprednisolone 16,17-acetonide |
| 6|A,9|A-Difluoro-11|A,16|A,17|A,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 16,17-acetonide |
| 67-73-2 |
| 6a,9a-difluoro-16a-hydroxyprednisolone 16,17-acetonide |
| 6alpha-Fluorotriamcinolone acetonide |
| 6alpha,9-Difluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone |
| 6alpha,9alpha-Difluoro-11beta,16alpha,17alpha,21-tetrahydroxy-1,4-pregnadiene-3,20-dione |
| 6alpha,9alpha-Difluoro-11beta,16alpha,17alpha,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 16,17-Acetonide |
| 6alpha,9alpha-difluoro-11beta,21-dihydroxy-16alpha-17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione; |
| 6alpha,9alpha-Difluoro-16alpha-hydroxyprednisolone 16,17-acetonide |
| AB00383017_11 |
| AB00383017-10 |
| AB1010906 |
| AC-429 |
| AC1L1M1L |
| AC1Q6ACL |
| Acetonida de fluocinolona |
| Acetonida de fluocinolona [INN-Spanish] |
| Acetonide de fluocinolone |
| Acetonide de fluocinolone [INN-French] |
| acetonido de fluocinolona |
| ACN-043362 |
| AKOS015963144 |
| ARONIS24561 |
| AS-13690 |
| BC214761 |
| C-22503 |
| C24H30F2O6 |
| Capex |
| CAS-67-73-2 |
| CC-28473 |
| CCG-221165 |
| CCRIS 3250 |
| CHEBI:31623 |
| CHEMBL989 |
| component of Neo-Synalar |
| Coriphate |
| Cortiplastol |
| CS-2519 |
| D01825 |
| D02QJH |
| DB00591 |
| Derma-smoothe/fs |
| Dermalar |
| Dermatin (steroid) |
| difluoro-hydroxy-(2-hydroxyacetyl)-tetramethyl-[?]one |
| DSSTox_CID_20674 |
| DSSTox_GSID_40674 |
| DSSTox_RID_79533 |
| DTXSID0040674 |
| EBD4852 |
| EINECS 200-668-5 |
| F0657 |
| FEBLZLNTKCEFIT-VSXGLTOVSA-N |
| Flucinar |
| flucinolone |
| Flucort |
| Flucort-N |
| Flucort-N (TN) |
| Fluocet |
| Fluocet (TN) |
| Fluocinolon acetonid |
| Fluocinolonacetonid |
| Fluocinolonacetonidum |
| Fluocinolone (Acetonide) |
| Fluocinolone 16,17-acetonide |
| FLUOCINOLONE ACETONIDE |
| Fluocinolone acetonide (Flucort-N) |
| Fluocinolone acetonide (JP15/USP/INN) |
| Fluocinolone acetonide (JP17/USP/INN) |
| Fluocinolone acetonide [DCIT] |
| Fluocinolone acetonide [USAN:INN:JAN] |
| Fluocinolone acetonide [USAN:USP:INN:JAN] |
| fluocinolone acetonide dihydrate |
| Fluocinolone acetonide for peak identification, European Pharmacopoeia (EP) Reference Standard |
| Fluocinolone acetonide for system suitability, European Pharmacopoeia (EP) Reference Standard |
| Fluocinolone acetonide intravitreal implant |
| fluocinolone acetonide oil |
| Fluocinolone acetonide, analytical standard |
| Fluocinolone acetonide, European Pharmacopoeia (EP) Reference Standard |
| Fluocinolone Acetonide, pharmaceutical secondary standard; traceable to USP, PhEur and BP |
| Fluocinolone acetonide, United States Pharmacopeia (USP) Reference Standard |
| Fluocinolone acetonide(Flucort-N) |
| Fluocinoloneacetonide |
| Fluocinoloni acetonidum |
| Fluocinoloni acetonidum [INN-Latin] |
| Fluonid |
| Fluortriamcinolone Acetonide |
| Fluotrex |
| Fluovitif |
| Flupollon |
| Fluzon [Steroid] |
| Fs Shampoo |
| GTPL7077 |
| HMS2090I14 |
| HMS2230D13 |
| HMS3259G12 |
| HSDB 3083 |
| HY-B0415 |
| Iluvien |
| J10113 |
| Jellin |
| Localyn |
| Localyn Syntex |
| LS-118443 |
| Medidur |
| MFCD00010525 |
| MLS000028545 |
| MLS001076276 |
| MolPort-002-528-328 |
| NC00562 |
| NCGC00021301-04 |
| NCGC00021301-06 |
| NCGC00255654-01 |
| NCI60_042042 |
| Neo-Synalar |
| NSC 92339 |
| NSC-92339 |
| NSC92339 |
| Omniderm |
| Opera_ID_1295 |
| Percutina |
| PL000407 |
| Pregna-1,20-dione, 6,9-difluoro-11,12-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6.alpha.,11.beta.,16.alpha.)- |
| Pregna-1,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)-, (6.alpha.,11.beta.,16.alpha.)- |
| Pregna-1,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6.alpha.,11.beta.,16.alpha.)- |
| Pregna-1,20-dione, 6.alpha.,9-difluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone |
| Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,12-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6-alpha,11-beta,16-alpha)- |
| Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)- |
| Pregna-1,4-diene-3,20-dione, 6.alpha.,9-difluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone |
| Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone |
| Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone (8CI) |
| Prodermin |
| Radiocin |
| Retisert (TN) |
| RL04590 |
| RS 1401AT |
| RS-1401 AT |
| s2470 |
| SCHEMBL4795 |
| Sinalar |
| SMR000058329 |
| SR-01000000109 |
| SR-01000000109-2 |
| STOCK1N-55828 |
| Synalar |
| Synalar (TN) |
| Synalar-HP |
| Synamol |
| Synandone |
| Synandrone |
| Synemol |
| Synotic |
| Synsac |
| Tefunote |
| Tox21_110869 |
| Tox21_110869_1 |
| Tox21_302364 |
| UNII-0CD5FD6S2M |
| W-104704 |
| WLN: T F5 E5 B666 GO IO RV AHTTTT&J A BF CQ E FVIQ H H OF -A&BHO -B&ACEF |
| ydroxyprednisolone 16,17-acetonide |
| ZINC3977981 |
